Skip to Content

S433 200 mg (Carbamazepine extended-release 200 mg)

Pill imprint S433 200 mg has been identified as Carbamazepine extended-release 200 mg.

Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbamazepine extended-release
Imprint:
S433 200 mg
Strength:
200 mg
Color:
Gray / Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Prasco Laboratories
National Drug Code (NDC):
66993-0408
Inactive Ingredients:
citric acid monohydrate
silicon dioxide
lactose monohydrate
microcrystalline cellulose
polyethylene glycol
povidone
sodium lauryl sulfate
magnesium silicate
triethyl citrate
gelatin
FD&C Red No. 3
FD&C Yellow No. 6
ferric oxide yellow
FD&C Blue No. 2
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide